Liam Chen

University of Minnesota United States of America

Dr. Liam Chen is a Professor of Pathology and Neurosurgery at the University of Minnesota Medical School, USA, and the director of the Minnesota David Tomassoni Biorepository Center. He is also the director of the Neuropathology Division at the University of Minnesota Medical Center, USA. Dr. Chen received residency and fellowship training at Mass General Brigham Hospital and Harvard Medical School, USA. Dr. Chen has more than 100 scholarly works to his credit, including research articles, reviews, and book chapters. He is an associate editor for several neuropathology journals and a member of many journal editorial boards and national grant review bodies.

Liam Chen

1books edited

2chapters authored

Latest work with IntechOpen by Liam Chen

Neurodegenerative diseases share the common property of neuronal loss in the higher-order association and limbic cortices or the extrapyramidal and pyramidal motor systems. In addition, oligodendroglia, astrocytes, and microglia have been implicated in fundamental abnormalities of virtually every neurodegenerative disorder. The particular system affected, more importantly the distribution of the pathology, determines the clinical presentation. While the most common dementia and movement disorders, such as Alzheimer’s disease, Lewy body disease, and frontotemporal lobar degeneration with TDP-43 pathology, including amyotrophic lateral sclerosis, have been extensively studied, many less common, even rare neurodegenerative disorders have gained more attention in recent years. This shift in focus is perhaps driven, in part, by the severely underestimated financial costs associated with these diseases, as well as the immense emotional burden they impose on patients and their caregivers. This book presents the most recent developments in rare neurodegenerative disorders. Insights gained from the investigation of pathophysiological mechanisms of these rare disorders may lead to the development of therapeutic strategies for more prevalent neurodegenerative disorders. In addition to highlighting advancements in research, the book discusses the significant challenges faced by researchers and healthcare professionals in diagnosing and treating rare diseases. It emphasizes the critical need for continued funding and support for research, which is essential to improving patient outcomes and advancing our understanding of these complex conditions.

Go to the book